Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Inspire Medical Systems (INSP) Shares Outstanding (2017 - 2026)

Inspire Medical Systems' Shares Outstanding history spans 10 years, with the latest figure at $28.8 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 2.26% to $28.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.8 million, a 2.26% decrease, with the full-year FY2025 number at $28.6 million, down 3.9% from a year prior.
  • Shares Outstanding hit $28.8 million in Q1 2026 for Inspire Medical Systems, up from $28.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for INSP hit a ceiling of $30.0 million in Q3 2024 and a floor of $27.6 million in Q1 2022.
  • Historically, Shares Outstanding has averaged $29.1 million across 5 years, with a median of $29.3 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 6.12% in 2023 and later decreased 3.9% in 2025.
  • Tracing INSP's Shares Outstanding over 5 years: stood at $29.0 million in 2022, then increased by 1.9% to $29.6 million in 2023, then grew by 0.61% to $29.7 million in 2024, then dropped by 3.9% to $28.6 million in 2025, then rose by 0.78% to $28.8 million in 2026.
  • Business Quant data shows Shares Outstanding for INSP at $28.8 million in Q1 2026, $28.6 million in Q4 2025, and $29.1 million in Q3 2025.